Title: Angioplasty Balloons Market forecast to witness phenomenal growth opportunities by 2024
1Angioplasty Balloons Market Global Industry
Analysis Report, Share, Growth, Price Trends and
Forecast, 2017 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2Regional Analysis of Angioplasty Balloons Market
- U.S. angioplasty balloons market is forecast to
undergo robust growth over the forecast timeframe
due to increasing prevalence of cardiovascular
diseases. - Presence of major industry players in the region
along with the availability of advanced
technology will further aid industry expansion. - For instance, U.S. FDA approved Lutonix 035 (C.R.
Bard) in October 2014 and In.Pact Admiral
(Medtronic) in January 2015 for peripheral artery
disease treatment. - Germany angioplasty balloons market should
undergo rapid growth due to increasing incidence
of heart diseases. - The country has an advanced healthcare
infrastructure providing improved access for
cardiovascular disease. Presence of large number
of PCI centers and increasing spending on
cardiovascular diseases should augment future
industry expansion.
3Application Analysis of Angioplasty Balloons
Market
- Growing prevalence of cardiovascular diseases
such as coronary and peripheral artery disease
will drive angioplasty balloons market growth. - Growing obesity levels due to lifestyle changes
such as adoption of sedentary lifestyle with lack
of physical activity and consumption of fat and
sodium rich junk foods will further fuel growth. - Drug eluting angioplasty balloons are forecast to
exhibit robust growth over the forecast timeframe
owing to their advantages such as more homogenous
drug distribution. - Coronary angioplasty balloon segment is slated to
witness lucrative growth owing to the increasing
prevalence of coronary heart disease. - They decrease the risk of neoproliferative
response by dilating the target vessels with less
force.
4Competitive Market Share of Angioplasty Balloons
Market
- Prominent industry participants include
Medtronic, Abbott, Boston Scientific, C.R. Bard,
and BIOTRONIK. The industry players adopt
strategies such as acquisitions, geographical
expansion and new product launch in order to
enhance their market position. - For instance, in February 2015, Medtronic
launched In.Pact Admiral drug coated balloon in
U.S. for treatment of patients suffering from
peripheral artery disease.
5 Browse Full Market Research Report On
Angioplasty Balloons Market _at_ http//bit.ly/2uBGBw
m Request for an in-depth table of contents
for this report _at_ https//www.gminsights.com/reque
st-toc/upcoming/1912
6Stay In Touch Website www.gminsights.com Soci
al Media